3 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
Follow Relapse: new trials by email Literature Review of Relapse trials Research Report on Relapse
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis Treatment Arm - high dose ATG, Control Arm - standard of care - Graft-versus-host-disease, Relapse | Phase 2 | Terminated | AHS Cancer Control Alberta | 68 | 2020-07-01 | 2025-07-18 |
| ASCT for Relapsed APL After Molecular Remission autologous hematopoietic cell transplantation - Acute Promyelocytic Leukemia, Relapse | Phase 2 | Terminated | Shanghai Jiao Tong University School of Medicine | 5 | 2009-06-01 | 2014-12-02 |
| Efficacy of Topotecan and Lapatinib in Early Recurrent Ovarian or Peritoneal Cancer TOPOTECAN, LAPATINIB - Cancer, Ovarian | Phase 2 | Terminated | Centre Francois Baclesse | 39 | 2008-03-01 | 2009-04-28 |
Recurrence (3) · Graft vs Host Disease (1) · Leukemia, Promyelocytic, Acute (1) · Neoplasms (1)
Disease Attributes (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Leukemia (1) · Leukemia, Myeloid (1) · Leukemia, Myeloid, Acute (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
AHS Cancer Control Alberta (1) · Centre Francois Baclesse (1) · Shanghai Jiao Tong University School of Medicine (1)
Canada (1) · China (1) · France (1)
JIong HU, M.D. (1) · Jan Storek, MD (1)